Corcept Therapeutics | CORT - Operating Profit



Corcept Therapeutics reported $26.67M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Alaunos Therapeutics USD -755000 395K Dec/2024
ANI Pharmaceuticals USD 15.17M 11.02M Jun/2025
Ardelyx USD -14400000 22.52M Jun/2025
Aurora Cannabis CAD -20220000 56.44M Jun/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Canopy Growth CAD -22080000 1.74M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.36B 494M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Novartis USD 5.46B 2.06B Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
TG Therapeutics USD 34.84M 26.22M Jun/2025